What is Narin Apisarnthanarax's NPI number?

Narin Apisarnthanarax's National Provider Identifier (NPI) is 1669506663, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Narin Apisarnthanarax's specialty?

Narin Apisarnthanarax is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Narin Apisarnthanarax located?

Narin Apisarnthanarax's practice location on file with NPPES is 13938 Highway 3 Unit 100, Webster, TX 77598-1622.

What is Narin Apisarnthanarax's phone number?

The practice phone number listed in the NPPES registry for Narin Apisarnthanarax is (281) 332-9681.

Does Narin Apisarnthanarax accept Medicare?

Narin Apisarnthanarax is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Narin Apisarnthanarax's NPI active?

Yes — Narin Apisarnthanarax's NPI (1669506663) is active in the NPPES registry as of the last update on 2022-08-24.

IndividualActiveAccepts Medicare

Narin Apisarnthanarax, M.D.

NPI 1669506663 · Dermatology Physician · Webster, TX

Narin Apisarnthanarax, M.D. is a Dermatology Physician provider in Webster, TX (NPI 1669506663).

Provider details

NPI number: 1669506663
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: No
License: L3233 (TX)

Practice location

13938 Highway 3 Unit 100

Webster, TX 77598-1622

Phone: (281) 332-9681

Fax: (281) 332-5957

Street-level locationGet directions

More TX providers

Mailing address

13938 Highway 3

Webster, TX 77598-1622

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense L3233 (TX)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(81/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
3,779 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,576	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	575	$91
Destruction of Precancer Skin Growth, 1 Growth17000	375	$51
Destruction of Skin Growth, 1-14 Growths17110	367	$110
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	334	$129
Biopsy of Related Skin Growth, First Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 23 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Hydrocortisone	134	100
Triamcinolone Acetonide	132	109
Ketoconazole	118	68
Doxycycline Hyclate	84	50
Fluocinonide	63	39
Minoxidil	51	14
Betamethasone Dipropionate	41	35
Finasteride	36

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$3,982 across 177 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-03-14
Last updated: 2022-08-24
Certified: 2022-08-24

Frequently asked questions

What is Narin Apisarnthanarax's NPI number?: Narin Apisarnthanarax's National Provider Identifier (NPI) is 1669506663, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Narin Apisarnthanarax's specialty?: Narin Apisarnthanarax is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Narin Apisarnthanarax located?: Narin Apisarnthanarax's practice location on file with NPPES is 13938 Highway 3 Unit 100, Webster, TX 77598-1622.
What is Narin Apisarnthanarax's phone number?: The practice phone number listed in the NPPES registry for Narin Apisarnthanarax is (281) 332-9681.
Does Narin Apisarnthanarax accept Medicare?: Narin Apisarnthanarax is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Narin Apisarnthanarax's NPI active?: Yes — Narin Apisarnthanarax's NPI (1669506663) is active in the NPPES registry as of the last update on 2022-08-24.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,576	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	575	$91
Destruction of Precancer Skin Growth, 1 Growth17000	375	$51
Destruction of Skin Growth, 1-14 Growths17110	367	$110
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	334	$129
Biopsy of Related Skin Growth, First Growth

Drug

Part D claims (2024)

Beneficiaries

Hydrocortisone

134

100

Triamcinolone Acetonide

132

109

Ketoconazole

118

Doxycycline Hyclate

Fluocinonide

Minoxidil

Betamethasone Dipropionate

Finasteride

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$3,982 across 177 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments